Published data from the SURPASS clinical trial program shows that injection site reactions with tirzepatide occurred at rates comparable to other GLP-1 receptor agonists including semaglutide
You can start semaglutide on your next scheduled injection day, replacing tirzepatide with semaglutide
Investigators reported a 38% higher risk of kidney cancer in GLP-1 users compared to non-users, noting that while the result was marginally nonsignificant, it remains concerning due to the widespread use of these drugs
GLP-1 drugs typically start to exert their effects within the first few days to weeks of treatment
Yes, our Shapely weight loss program in East Whittier, California is designed with flexibility and accessibility in mind, ensuring that you can access it from any device with internet connectivity
Understanding the potential indirect mechanismsincluding rapid weight loss, electrolyte disturbances, and dehydrationcan help patients and clinicians manage these symptoms effectively